UVA "broad spectrum" UVA/UVB sun protection claims "misleading," L'Oreal maintains.
This article was originally published in The Tan Sheet
Executive Summary
UVA "BROAD SPECTRUM" PROTECTION LABELING CLAIMS "MISLEADING" when based on the labeling scheme set forth in the critical wavelength method, L'Oreal maintains in May 15 comments to FDA on the tentative final monograph for OTC sunscreens. According to the proposed UVA testing system, products fulfilling the criteria of a critical wavelength value greater than or equal to 370 nanometers would be allowed to use the "broad spectrum" labeling claim. L'Oreal opposes this declaration of sun protection, saying products "qualifying for a `broad spectrum' designation can offer highly different UVA protection levels."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning